PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
6.10%
Some net income increase while AVGO is negative at -1.99%. John Neff would see a short-term edge over the struggling competitor.
-1.69%
Negative yoy D&A while AVGO is 1.77%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-5800.00%
Negative yoy deferred tax while AVGO stands at 273.33%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
7.69%
Less SBC growth vs. AVGO's 16.33%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
46.99%
Less working capital growth vs. AVGO's 104.17%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
74.03%
AR growth while AVGO is negative at -162.50%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
31.67%
Some inventory rise while AVGO is negative at -69.70%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
68.52%
Lower AP growth vs. AVGO's 170.51%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
-12.90%
Negative yoy usage while AVGO is 88.34%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
471.43%
Some yoy increase while AVGO is negative at -87.50%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
34.65%
Operating cash flow growth similar to AVGO's 37.84%. Walter Schloss would see parallel improvements or market conditions in cash generation.
-1.63%
Both yoy lines negative, with AVGO at -9.26%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-174.33%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
39.84%
Liquidation growth of 39.84% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-11600.00%
We reduce yoy other investing while AVGO is 7.69%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-210.13%
Both yoy lines negative, with AVGO at -128.99%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-79.27%
Negative yoy issuance while AVGO is 54.90%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
2.39%
Buyback growth of 2.39% while AVGO is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.